Jesús Troya

Hospital Universitari i Politècnic La Fe — Spain

Medicine · Health Sciences

34h-index9.8kcitations132works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV/AIDS drug development and treatment(44), HIV Research and Treatment(41), HIV/AIDS Research and Interventions(36), COVID-19 Clinical Research Studies(21), HIV-related health complications and treatments(19)

Publications115 total

Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protocol
BMJ Open Respiratory Research·2025Open Access
Genotyping not required for sustained effectiveness of long-acting cabotegravir plus rilpivirine: evidence from the RELATIVITY cohort
AIDS·2025Open Access
Clinical outcomes of long‐acting cabotegravir and rilpivirine in people with <scp>HIV</scp> aged 60 and older: Real‐world data from the Spanish <scp>RELATIVITY</scp> cohort
HIV Medicine·2025· 1 citedOpen Access
Comparable Inflammatory and Metabolic Outcomes After Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Continuing Dolutegravir/Lamivudine in Virologically Suppressed Adults With HIV (INSTINCT/GESIDA10918 Study)
Clinical Infectious Diseases·2025· 4 citedOpen Access
A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study)
Journal of Antimicrobial Chemotherapy·2025
Long-acting cabotegravir and rilpivirine for the treatment of people with HIV: current landscape and challenges ahead
Journal of Antimicrobial Chemotherapy·2025· 1 cited
NiVEst study: Dimensions of stigma and quality of life in people living with HIV
2025Open Access
Artificial intelligence in neuro-oncology: methodological bases, practical applications and ethical and regulatory issues
Clinical & Translational Oncology·2025· 6 cited
Ultrasound for long-acting injectable cabotegravir and rilpivirine in transgender individuals with implants: a new opportunity for normalization
Journal of Antimicrobial Chemotherapy·2025· 1 cited
5PSQ-138 Satisfaction with cabotegarvir and rilpivirine long-acting in a real-world setting: preliminary data
2025Open Access
5PSQ-141 Impact of cabotegarvir and rilpivirine long-acting in quality of life of subjects in a real-world setting: preliminary data
2025Open Access
Long-Acting CAB Plus RPV: It's Not About Weight, It's About the Weight of the Evidence
Clinical Infectious Diseases·2025· 2 cited
P-561. Long-Acting Cabotegravir and Rilpivirine in HIV Individuals Over 60 years: a Real-World Study (RELATIVITY Cohort)
Open Forum Infectious Diseases·2025· 1 citedOpen Access
Chest X-Ray Deep Learning Comparative Diagnosis Using Visual and Semantic Similarity with Variational Autoencoders
SSRN Electronic Journal·2025Open Access
Why Tenofovir/Dolutegravir/Lamivudine if We Might Use Dolutegravir/Lamivudine
Clinical Infectious Diseases·2024Open Access
Artificial intelligence model for tumoral clinical decision support systems
Computer Methods and Programs in Biomedicine·2024· 7 citedOpen Access
Reasons Against Routine Determination of Plasma Trough Levels in People With HIV Treated With Intramuscular Long Acting Cabotegravir and Rilpivirine as of Today
Clinical Infectious Diseases·2024· 4 citedOpen Access
Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs: A Real-World Study
Infectious Diseases and Therapy·2024· 6 citedOpen Access
Real-life data of immune recovery using bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48–96 weeks of RETROBIC Study
Journal of Antimicrobial Chemotherapy·2024· 6 citedOpen Access
Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
Genome Medicine·2024· 1 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Pablo Ryan(23), Guillermo Cuevas(13), Paul Bastard(11), Ignacio de los Santos(10), Jorge Valencia(10), Adrian Gervais(9), Aurora Pujol(9), Lucy Bizien(8), Yacine Tandjaoui-Lambiotte(8), Tayfun Özçelık(8), Sevgi Keleş(8), Qiang Pan‐Hammarström(8), Jacques G. Rivière(7), Lennart Hammarström(7), Santiago Moreno(7), Salvador Resino(7), Jérémie Rosain(6), Quentin Philippot(6), Jérémy Manry(6), José Luis Franco(6)